微小变化病
安格普特4
局灶节段性肾小球硬化
蛋白尿
肾病综合征
医学
血管生成素
泌尿系统
膜性肾病
生物标志物
内科学
肾病
病理
肾小球肾炎
尿
胃肠病学
泌尿科
肾
内分泌学
糖尿病
生物
血管内皮生长因子受体
血管内皮生长因子
基因
生物化学
作者
Gabriel Cara‐Fuentes,Alfons Segarra,Cecilia Silva-Sánchez,Heiman Wang,Miguel A. Lanaspa,Richard J. Johnson,Eduardo H. Garin
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2017-04-25
卷期号:12 (4): e0176198-e0176198
被引量:20
标识
DOI:10.1371/journal.pone.0176198
摘要
Background Minimal Change Disease (MCD) is the most common type of nephrotic syndrome in children. Angiopoietin-like-4 (Angplt4) has been proposed as mediator of proteinuria in MCD. The aim of this study was to evaluate the role of Angptl4 as a biomarker in MCD. Methods Patients with biopsy-proven primary MCD, focal segmental glomerulosclerosis, membranous nephropathy (60, 52 and 52 respectively) and 18 control subjects had urinary and serum Angptl4 measured by Elisa. Frozen kidney tissue sections were stained for Angptl4. Results Angptl4 was not identified in glomeruli of MCD patients in relapse. Urinary Angptl4 levels were elevated in MCD in relapse as well as in patients with massive proteinuria due to other glomerular diseases. Conclusion Neither serum nor urine Angptl4 appear to be good biomarkers in MCD. Elevated urinary Angptl4 n glomerular disease appears to reflect the degree of proteinuria rather than any specific disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI